🏛️ Verified NIH Record • Updated 2026-08-12
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) (NCT06808477)
🟢 Recruiting Phase1 💊 Investigational Drug / Biologic Sponsor: Bambusa Therapeutics
🩺 Plain-English Summary (8th-Grade Level)
This is a Phase 1, randomized, blinded, placebo controlled, single-ascending dose (SAD) and multiple-ascending dose (MAD) study of BBT001 in healthy volunteers (HVs) and adult patients with moderate to severe Atopic Dermatitis (AD).
Who can join: Review the eligibility criteria below.
Location: First OC Dermatology — Irvine, California
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- First OC Dermatology — Irvine, California
- OptiSkin Medical — New York, New York
- Equity Medical, LLC — The Bronx, New York
- Fremantle Dermatology — Fremantle, Western Australia
- Linear Clinical Research — Perth, Western Australia
- Optimal Clinical Trials Central Auckland — Grafton, Auckland
- Aotearoa Clinical Trials — Otahuhu, Auckland
- Pacific Clinical Research Network (PCRN) - Auckland — Takapuna, Auckland
- Optimal Clinical Trials Ltd - Christchurch — Christchurch,
- Pacific Clinical Research Network (PCRN) Wellington — Upper Hutt,
- Wojewódzki Specjalistyczny Szpital im. Dr. Wł. Biegańskiego w Łodzi — Lodz,
- Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie — Rzeszów,
- Państwowy Instytut Medyczny MSWiA — Warsaw,
- Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spółka Partnerska — Wroclaw,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.